4
Changes in Ownership
Aprea Therapeutics, Inc. Filed Acc 0001104659-26-009206
President/CEO bought 28,100 shares at $0.89 ($25,009)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gilad Oren President/CEO | 2026-01-30 | Purchase | +28,100 | $0.89 | $25,009 | 373,720 | D |
| Derivatives | |||||||
| Gilad Oren President/CEO | 2026-01-30 | Purchase · Common Warrant | +28,100 | 28,100 | D | ||
| Open-market purchases · 28,100 sh · avg $0.89 · $25,009 | |||||||
Loading xslF345X05/tm264801-2_4seq1.xml…